1887
  1. Home
  2. A-Z Publications
  3. Journal of Emergency Medicine, Trauma and Acute Care
  4. Volume 2020, Issue 2
  5. Article
Volume 2020, Issue 2
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

The World Health Organization (WHO) and member countries aimed to eliminate measles by 2020. In 1997, the Regional Committee for the Eastern Mediterranean (EMR) had unanimously adopted a resolution for measles elimination reduction goals for the interruption of measles transmission in EMR countries by 2010.1,2,3 Among Gulf Cooperation Council (GCC) countries of the Eastern Mediterranean Region of WHO, Oman and Bahrain accomplished this goal and were certified. However, those countries noted a resurgence of measles cases in 2018–2019 and integrated measles-related goals in their health plans beyond 2020. Documentation of GCC countries’ achievements and setbacks from 2015 to 2019 was conducted with data from WHO, UNICEF, and published related literature. An analysis of underlying factors, such as gross domestic product per capita, the ratio of nationals to expatriate population, seasonal reporting of measles, and their relation to the achievements, limitations, and subsequent challenges of the last five years in these countries are described. The lessons learned in GCC countries included heightened national commitment toward measles elimination, surveillance, allocation of dedicated human resources, and adept public health strategies, which could help professionals worldwide to realign their strategies and reset the goals for elimination of measles.

© 2021 Al Awaidy, Omer, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2020.15
2021-02-17
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2020/2/jemtac.2020.15.html?itemId=/content/journals/10.5339/jemtac.2020.15&mimeType=html&fmt=ahah

References

  1. World Health Organization. Regional Committee for the Eastern Mediterranean. Fifty-eighth Session. Agenda item 4 (b). Cairo, Egypt, 2–5 October 2011. Scaling up the Expanded Programme on Immunization to meet global and regional targets (EM/RC58/R.5) Available from: http://applications.emro.who.int/docs/RC_resolutions_2011_r5_13972.pdf?ua = 1.
  2. World Health Organization. Regional Committee for the Eastern Mediterranean. Sixty-second Session. Agenda item 2(a). Kuwait, 5–8 October 2015. Annual report of the Regional Director for 2014 (EM/RC62/R.1) Available from: http://applications.emro.who.int/docs/RC62_Resolutions_2015_R1_16570_EN.pdf?ua = 1.
  3. Teleb N, Atta H, Hajjeh R. Measles and rubella elimination in the Eastern Mediterranean Region: successes and challenges. East Mediterr Health J. 2019; 25:(10):667–668. https://doi.org/10.26719/2019.25.10.667.
     [Google Scholar]
  4. Bester JC. Measles and measles vaccination: a review. JAMA Pediatr. 2016; 170:(12):1209–15. doi:10.1001/jamapediatrics.2016.1787 [published Online First: 2016/01/01].
     [Google Scholar]
  5. Portnoy A, Jit M, Ferrari M, Hanson M, Brenzel L, Verguet S. Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis. Lancet Glob Health. 2019; 7:(4):e472–81. DOI: https://doi.org/10.1016/S2214-109X(18)30537-0 [published Online First: 2019/02/29].
     [Google Scholar]
  6. Gignoux E, Polonsky J, Ciglenecki I, Bichet M, Coldiron M, Lwiyo ET, et al. Risk factors for measles mortality and the importance of decentralized case management during an unusually large measles epidemic in eastern Democratic Republic of Congo in 2013. PloS one. 2018; 13:(3). doi.org/10.1371/journal.pone.01942760 [published Online First: 2018/03/14].
     [Google Scholar]
  7. Centre for disease prevention and control. Measles vaccine in Vaccine and preventable diseases. Available from: https://www.cdc.gov/vaccines/vpd/measles/index.html [published Online First: 2020/03/16].
  8. Strebel PM, Papania MJ, Fiebelkorn AP, Halsey NA. Measles vaccine. Vaccines. 2012; 6:352–87. doi.org/10.1016/B978-1-4557-0090-5.00028-8 [published Online First: 2012/10/01].
     [Google Scholar]
  9. World Health Organization Summary of the WHO position on Measles Vaccine April–2017. Available from: https://www.who.int/immunization/policy/position_papers/WHO_PP_measles_vaccine_summary_2017.pdf?ua = 1 [published Online First: 2012/04/08].
  10. Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, et al.. Progress Toward Regional Measles Elimination - Worldwide, 2000–2018. MMWR Morb Mortal Wkly Rep. 2019; 68:(48):1105-1111. [published Online First: 2019/12/06].
     [Google Scholar]
  11. Hinman AR, Orenstein WA. Collaborating to achieve Global Vaccine Action Plan goals. Lancet. 2017; 390:(10093):451-452. DOI: 10.1016/S0140-6736(17)31370–3 [published Online First: 2017/02/25].
     [Google Scholar]
  12. World Health Organization. Key facts on Measles. Available from: https://www.who.int/news-room/fact-sheets/detail/measles [published Online First: 2020/03/16].
  13. World Health Organization. Measles and Rubella Surveillance Data in Immunization, Vaccines and Biologicals. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/ [published Online First: 2020/03/16].
  14. Sarkar S, Zlojutro A, Khan K, Gardner L. Measles resurgence in the USA: how international travel compounds vaccine resistance. Lancet Infect Dis. 2019; 19:(7):684–6. doi: 10.1016/S1473-3099(19)30231-2 [published Online First: 2019/07/19].
     [Google Scholar]
  15. Béraud G, Abrams S, Beutels P, Dervaux B, Hens N. Resurgence risk for measles, mumps and rubella in France in 2018 and 2020. Euro Surveill. 2018; 23:(25). [published Online First: 2018/07/21].
     [Google Scholar]
  16. Daugherty MA, Hinman AR, Cochi SL, Garon JR, Rodewald LE, Nowak G, et al. The Global Vaccine Action Plan - insights into its utility, application, and ways to strengthen future plans. Vaccine. 2019; 37:(35):4928–4936. Doi: 10.1016/j.vaccine.2019.07.042 [published Online First: 2019/08/14].
     [Google Scholar]
  17. World Health Organization. Validation of elimination of trachoma as a public health problem. World Health Organization; 2016. Available from: https://apps.who.int/iris/bitstream/handle/10665/208901/WHO-HTM-NTD-2016.8-eng.pdf [published Online First: 2020/04/20].
  18. Al Awaidy ST, Khamis F. Wild Poliovirus Type 1 in Oman: A re-emerging threat that requires urgent, targeted and strategic preparedness. Sultan Qaboos Univ Med J. 2020; 20:(1):e1. doi.org/10.18295/squmj.2020.20.01.001 [published Online First: 2020/01/01].
     [Google Scholar]
  19. World Health Organization. Measles elimination and prevention of congenital Rubella syndrome in the Eastern Mediterranean region. Action Plan 2006–2010. Available from: http://www.emro.who.int/images/stories/vpi/documents/measlesplan_2006_2010.pdf?ua = 1 [published Online First: 2020/04/08].
  20. World Health organization. Global Measles and Rubella strategic Plan 2012–2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/44855/9789241503396_eng.pdf;jsessionid = 333586764A431AED638D1D35CDF9A26C?sequence = 1 [published Online First: 2020/04/08].
  21. Teleb N, Lebo E, Ahmed H, Hossam AR, El Sayed el T, Dabbagh A, et al. Progress toward measles elimination–Eastern Mediterranean Region, 2008–2012. MMWR Morb Mortal Wkly Rep. 2014; 63:(23):511–5. [published Online First: 2014/06/13].
     [Google Scholar]
  22. Kmeid M, Azouri H, Aaraj R, Bechara E, Antonios D. Vaccine coverage for Lebanese citizens and Syrian refugees in Lebanon. Int Health. 2019; 11:(6):568–579. DOI: 10.1093/inthealth/ihz023 [published Online First: 2019/11/13].
     [Google Scholar]
  23. Aloosh M, Salavati A, Aloosh A. Economic sanctions threaten population health: the case of Iran. Public Health. 2019; 169::10–13. DOI: 10.1016/j.puhe.2019.01.006 [published Online First: 2019/04/01].
     [Google Scholar]
  24. El Bcheraoui C, Jumaan AO, Collison ML, Daoud F, Mokdad AH. Health in Yemen: losing ground in war time. Global Health. 2018; 14:(1):42. DOI: 10.1186/s12992-018-0354-9 [published Online First: 2018/04/25].
     [Google Scholar]
  25. World Health Organization. Reported Measles Cases by WHO Region, 2019, in Measles and Rubella surveillance data. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/ [published Online First: 2020/03/17].
  26. World Health Organization. Global Measles and Rubella Update March 2020. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/ [published Online First: 2020/03/26].
  27. Goodson JL, Taleb N, Ashmony H, Musa N, Ghoniem A, Hassan Q, et al. Progress towards Measles elimination–Eastern Mediterranean Region 2013–19 in World Health Organization Weekly Epidemiological record. 2020;95:148–59. Available from: http://extranet.who.int/iris/restricted/bitstream/handle/10665/331774/WER9516-eng-fre.pdf [published Online First: 2020/04/18].
  28. Awaidy ST, Baqlani SA, Mahrouqi SA, Rawahi BA, Busaidi SA, Obaidani IA, et al. Progress Towards Measles Elimination: Oman Experience. SM Vaccine Vaccin. 2015; 1:(1):1004–9. [published Online First: 2015/08/24].
     [Google Scholar]
  29. World Health Organization. Regional office of Eastern Mediterranean. Measles and Rubella surveillance summary and data analysis of selected indicators in Measles & Rubella monthly Bulletin. Available from: http://www.emro.who.int/vpi/publications/measles-archived-monthly-bulletin.html [published Online First: 2020/04/02].
  30. Al Awaidy ST. Impact of strategies and activities for reducing morbidity and mortality of vaccine-preventable diseases in Oman: A status report. J Vaccines Immun 2015, 3:(1):1–6. doi.org/10.14312/2053-1273.2015-1 [published Online First: 2014/01/30].
     [Google Scholar]
  31. Jawad JS, Al-Sayyad AS, Sataih F, Naouri B, Alexander JP. Toward measles elimination in Bahrain—A Middle East country experience. J Infect Dis. 2011; 204: S299–304. DOI: 10.1093/infdis/jir105 [published Online First: 2011/07/20].
     [Google Scholar]
  32. Memish ZA, Khan AA, Ebrahim S. Measles and the 2019 Hajj: the risk of magnifying the global measles surge. J Travel Med. 2019; 26:(6):taz041. DOI: 10.1093/jtm/taz041 [published Online First: 2019/09/02].
     [Google Scholar]
  33. Al-Abdullah N. A measles outbreak in a refugee community in Jeddah City, Saudi Arabia. Journal of Hospital Infection. 2018; 100:(4):e264–5. DOI: 10.1016/j.jhin.2018.05.018 [published Online First: 2018/12/01].
     [Google Scholar]
  34. Ismayl G, Barqawi HJ, Harous A, Balchi M, AbuZahra D, AlMazrouei G, et al. Evaluation of knowledge of the United Arab Emirates population on measles and its control, following a nationwide campaign. Avicenna J Med. 2020; 10:(1):35. DOI: 10.4103/ajm.ajm_56_19 [published Online First: 2020/01/20].
     [Google Scholar]
  35. Mokdad AH. The Global Burden of Disease: A critical resource for informed policy making in the Gulf region. Journal of Health Specialties. 2016; 4:(3):162. DOI: 10.4103/2468-6360.186482 [published Online First: 2016/07/18].
     [Google Scholar]
  36. UNICEF /WHO. Progress Towards Global Immunization Goals. Summary presentation of key indicators. Available from: https://www.who.int/immunization/monitoring_surveillance/SlidesGlobalImmunization.pdf?ua = 1 [published Online First: 2019/07/01].
  37. UNICEF data. Monitoring the situation of children and women. Available from: http://data.unicef.org/country/[published Online First: 2020/04/14].
  38. Progress WHO. towards regional measles elimination-worldwide, 2000-2016. Weekly Epidemiological. Record. 2017; 43:649. DOI: http://dx.doi.org/10.15585/mmwr.mm6642a6External .
     [Google Scholar]
  39. Taryam MM, Hammadi HM, Al Faisal W, Hussein HY, AlSerkal FY, Monsef NA. Mass vaccination against measles among private schools population of Dubai 2015–2016, coverage, refusal and response rates. Int J Ped Neo Heal. 2017; 1:7–12. DOI: 10.25141/2572-4355-2017-1.0007 [published Online First: 2017/02/17].
     [Google Scholar]
  40. Dube E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the antivaccine movement: influence, impact and implications. Expert review of vaccines. 2015; 14:(1):99–117. doi.org/10.1586/14760584.2015.964212 [published Online First: 2014/11/16].
     [Google Scholar]
  41. Arif N, Al-Jefri M, Bizzi IH, Perano GB, Goldman M, Haq I, et al. Fake news or weak science? Visibility and characterization of antivaccine webpages returned by Google in different languages and countries. Frontiers in immunology. 2018; 9:1215. doi: 10.3389/fimmu.2018.01215 [published Online First: 2018/06/05].
     [Google Scholar]
  42. Kaddar M, Saxenian H, Senouci K, Mohsni E, Sadr-AzodiN. Vaccine procurement in the Middle East and North Africa region: Challenges and ways of improving program efficiency and fiscal space. Vaccine. 2019 May 23. doi: 10.1016/j.vaccine.2019.04.029 [published Online First: 2019/06/12].
     [Google Scholar]
  43. DeRoeck D, Bawazir SA, Carrasco P, Kaddar M, Brooks A, Fitzsimmons J, et al. Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. Int J Health Plann Manage. 2006; 21:(1):23–43. doi: 10.1002/hpm.822 [published Online First: 2006/03/03].
     [Google Scholar]
  44. Naouri B, Ahmed H, Bekhit R, Teleb N, Mohsni E, Alexander JP. Progress toward measles elimination in the Eastern Mediterranean Region. J Infect Dis. 2011; 204:S289–98. doi.org/10.1586/14760584.2013.814847 [published Online First: 2014/01/09].
     [Google Scholar]
  45. Al-Abri SS, Al-Rawahi B, Abdelhady D, Al-Abaidani I Effective vaccine management and Oman's healthcare system's challenge to maintain high global standards. J Infect Public Health. 2018; 11:(5):742–4. doi.org/10.1016/j.jiph.2018.04.015 [published Online First: 2014/01/09].
     [Google Scholar]
  46. World Health Organization. Guide for clinical case management, prevention and control during measles outbreak. WHO, Geneva, Switzerland. Available from: https://apps.who.int/iris/bitstream/handle/10665/331599/9789240002869-eng.pdf. [published Online First: 2020/04/12].
  47. WHO–EMR. Setting strategic agenda for WHO cooperation in Country cooperation Strategies for WHO and Oman 2018–2022. 2017 page 25. WHO-EM/PME/007/E. http://applications.emro.who.int/docs/CCS_Oman_2017_EN_16764.pdf [published Online First: 2020/04/09].
  48. WHO. WHO country cooperation, strategic Agenda 2017–2022 in Country cooperation strategy at a glance; Saudi Arabia. Available from: https://apps.who.int/iris/bitstream/handle/10665/136842/ccsbrief_sau_en.pdf?sequence = 1&isAllowed = y [published Online First: 2020/04/09].
  49. Ferrari MJ, Grenfell BT, Strebel PM. Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control. Philos Trans R Soc Lond B Biol Sci. 2013; 368:(1623):20120141. DOI: 10.1098/rstb.2012.0141 [published Online First: 2015/08/05].
     [Google Scholar]
  50. Almazroui M, Nazrul Islam M, Athar H, Jones PD, Rahman MA. Recent climate change in the Arabian Peninsula: annual rainfall and temperature analysis of Saudi Arabia for 1978–2009. Int J Climatol. 2012; 32:(6):953–66. https://doi.org/10.1002/joc.3446 [published Online First: 2012/03/12].
     [Google Scholar]
  51. Kalyani D, Shankar K. Assessment and seasonal variations of communicable diseases: 3-year study. Int J Res Med Sci. 2016; 4:(4):1186–92. [published Online First: 2015/04/01].
     [Google Scholar]
  52. He D, Dushoff J, Day T, Ma J, Earn DJ. Mechanistic modelling of the three waves of the 1918 influenza pandemic. Theor Ecol. 2011; 4:(2):283–8. DOI: 10.1007/s12080-011-0123-3 [published Online First: 2011/05/01].
     [Google Scholar]
  53. Buckee CO, Tatem AJ, Metcalf CJ. Seasonal population movements and the surveillance and control of infectious diseases. Trends Parasitol. 2017; 33:(1):10–20. doi: 10.1016/j.pt.2016.10.006 [published Online First: 2018/01/01].
     [Google Scholar]
  54. World Health Organization. Office of Eastern Mediterranean region. Country profile. Available from: https://www.who.int/countries/bhr/en/ [published Online First: 2020/04/02].
  55. General Authority of Statistics. Kingdom of Saudi Arabia. Arab Gulf Council in Statistical Year Book. Available from: https://www.stats.gov.sa/en/page/42 [published Online First: 2020/04/02] Accessed on 2/4/2020.
  56. “World Economic Outlook Database, October 2019.” World Economic Outlook. International Monetary Fund. Retrieved 1 January 2020. Available from: https://www.imf.org/external/pubs/ft/weo/2019/02/weodata/index.aspx [published Online First: 2019/10/01].
  57. World Bank national accounts data, and OECD National Accounts data files. Available from: https://data.worldbank.org/indicator/NY.GDP.MKTP.CD Retrieved 1 January 2020.
  58. Ahmed A, Lee KS, Bukhsh A, Al-Worafi YM, Sarker MM, Ming LC, et al. Outbreak of vaccine-preventable diseases in Muslim majority countries. J Infect Public Health. 2018; 11:(2):153–5. doi: 10.1016/j.jiph.2017.09.007 [published Online First: 2018/03/01].
     [Google Scholar]
  59. Nurunnabi M. Transformation from an oil-based economy to a knowledge-based economy in Saudi Arabia: the direction of Saudi vision 2030. Journal of the Knowledge Economy. 2017; 8:(2):536–64. DOI: 10.1007/s13132-017-0479-8 [published Online First: 2017/06/01].
     [Google Scholar]
  60. Al-Riyami A. Health vision 2050 Oman: a committed step towards reforms. Oman Med J. 2012; 27:(3):190. DOI: 10.5001/omj.2012.43 [published Online First: 2012/06/01].
     [Google Scholar]
  61. Khoja T, Rawaf S, Qidwai W, Rawaf D, Nanji K, Hamad A. Health care in Gulf Cooperation Council countries: a review of challenges and opportunities. Cureus. 2017; 9:(8). DOI: 10.7759/cureus.1586 [published Online First: 2017/08/21].
     [Google Scholar]
  62. Corona virus (COVID 19) Pandemic. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [published Online First: 2020/04/12].
  63. Greene CJ, Burleson SL, Crosby JC, Heimann MA, Pigott DC. Coronavirus disease 2019: International public health considerations. J Am Coll Emerg Physicians Open. 2020. doi: 10.1002/emp2.12040 [published Online First: 2020/02/27].
     [Google Scholar]
  64. Gautret P, Steffen R. Communicable diseases as health risks at mass gatherings other than Hajj: what is the evidence? Int J Infect Dis. 2016; 47:46–52. https://doi.org/10.1016/j.ijid.2016.03.007.
     [Google Scholar]
  65. Hoang VT, Gautret P. Measles outbreaks at mass gathering mostly occur at youth events. Lancet Infect Dis. 2020; 20: 23. https://doi.org/10.1016/S1473-3099(19)30685-1.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2020.15
Loading
Efforts for measles elimination in the Gulf Cooperation Council countries 2015–2019: A review
Journal of Emergency Medicine, Trauma and Acute Care 2020, 15 (2021); https://doi.org/10.5339/jemtac.2020.15
/content/journals/10.5339/jemtac.2020.15
/content/journals/10.5339/jemtac.2020.15
Loading

Data & Media loading...

  • Article Type: Review Article
Keyword(s): epidemiology, GCC, Gulf cooperation council countries and measles elimination

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error